|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
43,790,000 |
Market
Cap: |
2.56(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$42.85 - $75.36 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Immunocore Holdings is a late-stage biotechnology company focusing on the development of a class of T cell receptors, or TCR, bispecific immunotherapies called ImmTAX, Immune mobilizing monoclonal TCRs Against X disease, designed to treat a range of diseases, including cancer, infectious and autoimmune. Co.'s platforms include: ImmTAC, which focuses on the treatment of solid tumors; ImmTAV, which includes IMC-I109V, its ImmTAV molecule targeting a conserved hepatitis B virus envelope antigen; and ImmTAAI, which utilizes its ImmTAX platform to generate product candidates designed to provide targeted immunosuppression for the treatment of autoimmune diseases.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
124,375 |
128,750 |
128,750 |
128,750 |
Total Sell Value |
$8,694,739 |
$9,000,520 |
$9,000,520 |
$9,000,520 |
Total People Sold |
2 |
2 |
2 |
2 |
Total Sell Transactions |
4 |
5 |
5 |
5 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
St Leger Tina Amber |
CHIEF HR OFFICER |
|
2024-04-01 |
4 |
AS |
$64.06 |
$280,263 |
D/D |
(4,375) |
0 |
|
-7% |
|
St Leger Tina Amber |
CHIEF HR OFFICER |
|
2024-04-01 |
4 |
OE |
$29.87 |
$130,681 |
D/D |
4,375 |
4,375 |
|
- |
|
Berman David M |
HEAD OF R&D |
|
2024-02-28 |
4 |
AS |
$67.61 |
$2,504,158 |
D/D |
(36,509) |
0 |
|
-16% |
|
Berman David M |
HEAD OF R&D |
|
2024-02-28 |
4 |
OE |
$17.46 |
$637,447 |
D/D |
36,509 |
36,509 |
|
- |
|
Berman David M |
HEAD OF R&D |
|
2024-02-27 |
4 |
AS |
$69.45 |
$3,893,030 |
D/D |
(54,938) |
0 |
|
-17% |
|
Berman David M |
HEAD OF R&D |
|
2024-02-27 |
4 |
OE |
$17.46 |
$959,217 |
D/D |
54,938 |
54,938 |
|
- |
|
Berman David M |
HEAD OF R&D |
|
2024-02-26 |
4 |
AS |
$70.60 |
$2,017,288 |
D/D |
(28,553) |
0 |
|
-18% |
|
Berman David M |
HEAD OF R&D |
|
2024-02-26 |
4 |
OE |
$17.46 |
$498,535 |
D/D |
28,553 |
28,553 |
|
- |
|
St Leger Tina Amber |
Chief HR Officer |
|
2024-01-03 |
4 |
AS |
$69.85 |
$305,781 |
D/D |
(4,375) |
0 |
|
-17% |
|
St Leger Tina Amber |
Chief HR Officer |
|
2024-01-03 |
4 |
OE |
$29.87 |
$130,681 |
D/D |
4,375 |
4,375 |
|
- |
|
Ratcliffe Peter John |
Director |
|
2024-01-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
333 |
|
-19% |
|
Di Donato Brian |
Chief Financial OfficerOfficer |
|
2024-01-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
19,230 |
|
-19% |
|
Bell John Irving |
Director |
|
2024-01-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,452 |
|
-19% |
|
13 Records found
|
1
|
Page 1 of 1 |
|
|